Schriesheim, Germany

Mandy Roscher

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mandy Roscher

Introduction

Mandy Roscher is a prominent inventor based in Schriesheim, Germany. She has made significant contributions to the field of virology, particularly in the production and purification of parvoviruses. Her work is crucial for advancing research and therapeutic applications involving these viruses.

Latest Patents

Mandy Roscher holds a patent for a "Method for large scale production and purification of parvovirus." This patent describes a reproducible, effective, and scalable process for parvovirus production, including characterization strategies, with a preference for the production of H-1PV. This innovation is vital for enhancing the efficiency of parvovirus research and applications.

Career Highlights

Mandy is affiliated with the Deutsches Krebsforschungszentrum, where she applies her expertise in virology. Her work at this esteemed research center has positioned her as a key figure in the scientific community, contributing to advancements in cancer research and viral therapies.

Collaborations

Mandy collaborates with notable colleagues, including Barbara Leuchs and Marcus Müller. These partnerships enhance her research efforts and contribute to the overall success of their projects.

Conclusion

Mandy Roscher's innovative work in the field of parvovirus production and purification exemplifies her dedication to advancing scientific research. Her contributions are paving the way for future developments in virology and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…